MUSC Hollings Cancer Center (HCC) — Charleston, South Carolina

MUSC Hollings Cancer Center (HCC) is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MUSC Hollings Cancer Center (HCC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemias.

Sponsors: Syndax Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC Hollings Cancer Center (HCC)?

MUSC Hollings Cancer Center (HCC) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC Hollings Cancer Center (HCC) conducted?

MUSC Hollings Cancer Center (HCC) has 1 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemias.

Is MUSC Hollings Cancer Center (HCC) accredited by Crixeo Health?

MUSC Hollings Cancer Center (HCC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC Hollings Cancer Center (HCC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.